Psychopharmacology Update: 2024
Live Webinar
Nov 14, 2024
2.5 AMA PRA Category 1 Credits™ OVERVIEW
Psychopharmacology Update: 2024 is organized by Maryland Psychiatric Society, Inc. (MPS) and will be held on Nov 14, 2024.
Objectives:
At the conclusion of the activity participants will be able to:
- Highlight both current and emerging pharmacologic strategies in the treatment of all common sleep disorders, ranging from insomnia to hypersomnia, and even sleep-disordered breathing.
- Describe the DSM-5 diagnosis of Gambling Disorder, screening tools, treatments and services available in Maryland
- Understand ongoing clinical research in the psychedelic medicine, psilocybin, and considerations for future clinical use
KEY DATES
14 Nov, 2024
Event Start Date
14 Nov, 2024
Event End Date
ACCREDITATION & CREDITS
Accreditation and Designation Statement:
In support of improving patient care, this activity has been planned and implemented by American Psychiatric Association (APA) and the Maryland Psychiatric Society. APA is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The APA designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
TARGET AUDIENCE
PhysicianHealthcare ProfessionalsNursesPsychiatristsPsychologistsSPECIALITIES
PsychologyClinical Pharmacology
Quick Links